Life and death in the thymus-cell death signaling during T cell development

Current Opinion in Cell Biology

Volumn 22, Issue 6, 2010, Pages 865-871

  Hernandez, Jeniffer B ^a   Newton, Ryan H ^a   Walsh, Craig M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 7; PROTEIN BCL 2;

CD4 CD8 RATIO; CELL DEATH; CELL MATURATION; CELL SUBPOPULATION; CELL SURVIVAL; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; THYMOCYTE;

ANIMALS; ANTIGENS, CD; CELL DEATH; CELL DIFFERENTIATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; THYMUS GLAND;

EID: 78649631191     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2010.08.003     Document Type: Review

References (57)

1. Godfrey D., Kennedy J., Suda T., Zlotnik A. A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8- triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J Immunol 1993, 150:4244-4252.
2. Ciofani M., Zuniga-Pflucker J.C. A survival guide to early T cell development. Immunol Res 2006, 34:117-132.
3. Rodewald H.R., Kretzschmar K., Swat W., Takeda S. Intrathymically expressed c-kit ligand (stem cell factor) is a major factor driving expansion of very immature thymocytes in vivo. Immunity 1995, 3:313-319.
4. von Freeden-Jeffry U., Vieira P., Lucian L.A., McNeil T., Burdach S.E., Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 1995, 181:1519-1526.
5. Peschon J.J., Morrissey P.J., Grabstein K.H., Ramsdell F.J., Maraskovsky E., Gliniak B.C., Park L.S., Ziegler S.F., Williams D.E., Ware C.B., et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 1994, 180:1955-1960.
6. Kondo M., Akashi K., Domen J., Sugamura K., Weissman I.L. Bcl-2 rescues T lymphopoiesis, but not B or NK cell development, in common gamma chain-deficient mice. Immunity 1997, 7:155-162.
7. Pellegrini M., Bouillet P., Robati M., Belz G.T., Davey G.M., Strasser A. Loss of Bim increases T cell production and function in interleukin 7 receptor-deficient mice. J Exp Med 2004, 200:1189-1195.
8. Opferman J.T., Letai A., Beard C., Sorcinelli M.D., Ong C.C., Korsmeyer S.J. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 2003, 426:671-676.
9. Li W.Q., Jiang Q., Khaled A.R., Keller J.R., Durum S.K. Interleukin-7 inactivates the pro-apoptotic protein Bad promoting T cell survival. J Biol Chem 2004, 279:29160-29166.
10. Khaled A.R., Kim K., Hofmeister R., Muegge K., Durum S.K. Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH. Proc Natl Acad Sci USA 1999, 96:14476-14481.
11. Dunkle A., Dzhagalov I., He Y.W. Mcl-1 promotes survival of thymocytes by inhibition of Bak in a pathway separate from Bcl-2. Cell Death Differ 2010, 17:994-1002.
12. Fehling H.J., Krotkova A., Saint-Ruf C., von Boehmer H. Crucial role of the pre-T-cell receptor alpha gene in development of alpha beta but not gamma delta T cells. Nature 1995, 375:795-798.
13. Mandal M., Borowski C., Palomero T., Ferrando A.A., Oberdoerffer P., Meng F., Ruiz-Vela A., Ciofani M., Zuniga-Pflucker J.C., Screpanti I., et al. The BCL2A1 gene as a pre-T cell receptor-induced regulator of thymocyte survival. J Exp Med 2005, 201:603-614.
14. Juntilla M.M., Wofford J.A., Birnbaum M.J., Rathmell J.C., Koretzky G.A. Akt1 and Akt2 are required for alphabeta thymocyte survival and differentiation. Proc Natl Acad Sci USA 2007, 104:12105-12110.
15. Trampont P.C., Tosello-Trampont A.C., Shen Y., Duley A.K., Sutherland A.E., Bender T.P., Littman D.R., Ravichandran K.S. CXCR4 acts as a costimulator during thymic beta-selection. Nat Immunol 2010, 11:162-170.
16. Walsh C., Wen B., Chinnaiyan A., O'Rourke K., Dixit V., Hedrick S. A role for FADD in T cell activation and development. Immunity 1998, 8:439-449.
17. Newton K., Harris A.W., Strasser A. FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor. EMBO J 2000, 19:931-941.
18. Bell B.D., Leverrier S., Weist B.M., Newton R.H., Arechiga A.F., Luhrs K.A., Morrissette N.S., Walsh C.M. FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells. Proc Natl Acad Sci USA 2008, 105:16677-16682.
19. Starr T.K., Jameson S.C., Hogquist K.A. Positive and negative selection of T cells. Annu Rev Immunol 2003, 21:139-176.
20. Sun Z., Unutmaz D., Zou Y.R., Sunshine M.J., Pierani A., Brenner-Morton S., Mebius R.E., Littman D.R. Requirement for RORgamma in thymocyte survival and lymphoid organ development. Science 2000, 288:2369-2373.
21. Thompson J., Burger M.L., Whang H., Winoto A. Protein kinase C regulates mitochondrial targeting of Nur77 and its family member Nor-1 in thymocytes undergoing apoptosis. Eur J Immunol 2010, 40:2041-2049.
22. Bouillet P., Metcalf D., Huang D.C., Tarlinton D.M., Kay T.W., Kontgen F., Adams J.M., Strasser A. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1999, 286:1735-1738.
23. Bouillet P., Purton J.F., Godfrey D.I., Zhang L.C., Coultas L., Puthalakath H., Pellegrini M., Cory S., Adams J.M., Strasser A. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 2002, 415:922-926.
24. Lu F.W., Yasutomo K., Goodman G.B., McHeyzer-Williams L.J., McHeyzer-Williams M.G., Germain R.N., Ashwell J.D. Thymocyte resistance to glucocorticoids leads to antigen-specific unresponsiveness due to "holes" in the T cell repertoire. Immunity 2000, 12:183-192.
25. Brewer J.A., Kanagawa O., Sleckman B.P., Muglia L.J. Thymocyte apoptosis induced by T cell activation is mediated by glucocorticoids in vivo. J Immunol 2002, 169:1837-1843.
26. Daniels M.A., Teixeiro E., Gill J., Hausmann B., Roubaty D., Holmberg K., Werlen G., Hollander G.A., Gascoigne N.R., Palmer E. Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling. Nature 2006, 444:724-729.
27. Gallo E.M., Winslow M.M., Cante-Barrett K., Radermacher A.N., Ho L., McGinnis L., Iritani B., Neilson J.R., Crabtree G.R. Calcineurin sets the bandwidth for discrimination of signals during thymocyte development. Nature 2007, 450:731-735.
28. Hogquist K.A. Signal strength in thymic selection and lineage commitment. Curr Opin Immunol 2001, 13:225-231.
29. Sohn S.J., Rajpal A., Winoto A. Apoptosis during lymphoid development. Curr Opin Immunol 2003, 15:209-216.
30. Fischer A.M., Katayama C.D., Pages G., Pouyssegur J., Hedrick S.M. The role of erk1 and erk2 in multiple stages of T cell development. Immunity 2005, 23:431-443.
31. Rincon M., Whitmarsh A., Yang D.D., Weiss L., Derijard B., Jayaraj P., Davis R.J., Flavell R.A. The JNK pathway regulates the In vivo deletion of immature CD4(+)CD8(+) thymocytes. J Exp Med 1998, 188:1817-1830.
32. Sabapathy K., Hu Y., Kallunki T., Schreiber M., David J.P., Jochum W., Wagner E.F., Karin M. JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. Curr Biol 1999, 9:116-125.
33. Sabapathy K., Kallunki T., David J.P., Graef I., Karin M., Wagner E.F. c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation. J Exp Med 2001, 193:317-328.
34. Gong Q., Cheng A.M., Akk A.M., Alberola-Ila J., Gong G., Pawson T., Chan A.C. Disruption of T cell signaling networks and development by Grb2 haploid insufficiency. Nat Immunol 2001, 2:29-36.
35. McCarty N., Paust S., Ikizawa K., Dan I., Li X., Cantor H. Signaling by the kinase MINK is essential in the negative selection of autoreactive thymocytes. Nat Immunol 2005, 6:65-72.
36. Sohn S.J., Lewis G.M., Winoto A. Non-redundant function of the MEK5-ERK5 pathway in thymocyte apoptosis. EMBO J 2008, 27:1896-1906.
37. Strasser A., Harris A.W., von Boehmer H., Cory S. Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bcl-2 transgene. Proc Natl Acad Sci USA 1994, 91:1376-1380.
38. Calnan B.J., Szychowski S., Chan F.K., Cado D., Winoto A. A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection. Immunity 1995, 3:273-282.
39. Thompson J., Winoto A. During negative selection, Nur77 family proteins translocate to mitochondria where they associate with Bcl-2 and expose its proapoptotic BH3 domain. J Exp Med 2008, 205:1029-1036.
40. Siegel R.M. Caspases at the crossroads of immune-cell life and death. Nat Rev Immunol 2006, 6:308-317.
41. Salmena L., Lemmers B., Hakem A., Matysiak-Zablocki E., Murakami K., Au P.Y., Berry D.M., Tamblyn L., Shehabeldin A., Migon E., et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev 2003, 17:883-895.
42. Chau H., Wong V., Chen N.J., Huang H.L., Lin W.J., Mirtsos C., Elford A.R., Bonnard M., Wakeham A., You-Ten A.I., et al. Cellular FLICE-inhibitory protein is required for T cell survival and cycling. J Exp Med 2005, 202:405-413.
43. Zhang N., He Y.W. An essential role for c-FLIP in the efficient development of mature T lymphocytes. J Exp Med 2005, 202:395-404.
44. Zhang D.W., Shao J., Lin J., Zhang N., Lu B.J., Lin S.C., Dong M.Q., Han J. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 2009.
45. He S.W., Lai, Miao L., Wang T., Du F., Zhao L., Wang X Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009, 137:1100-1111.
46. Cho Y.S., Challa S., Moquin D., Genga R., Ray T.D., Guildford M., Chan F.K. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 2009, 137:1112-1123.
47. Declercq W., Vanden Berghe T., Vandenabeele P. RIP kinases at the crossroads of cell death and survival. Cell 2009, 138:229-232.
48. Ch'en I.L., Beisner D.R., Degterev A., Lynch C., Yuan J., Hoffmann A., Hedrick S.M. Antigen-mediated T cell expansion regulated by parallel pathways of death. Proc Natl Acad Sci USA 2008, 105:17463-17468.
49. Leverrier S., Salvesen G.S., Walsh C.M. Enzymatically active single chain caspase-8 maintains T-cell survival during clonal expansion. Cell Death Differ 2010.
50. Lamhamedi-Cherradi S.E., Zheng S.J., Maguschak K.A., Peschon J., Chen Y.H. Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice. Nat Immunol 2003, 4:255-260.
51. Diehl G.E., Yue H.H., Hsieh K., Kuang A.A., Ho M., Morici L.A., Lenz L.L., Cado D., Riley L.W., Winoto A. TRAIL-R as a negative regulator of innate immune cell responses. Immunity 2004, 21:877-889.
52. Corazza N., Brumatti G., Jakob S., Villunger A., Brunner T. TRAIL and thymocyte apoptosis: not so deadly?. Cell Death Differ 2004, 11(Suppl 2):S213-215.
53. Simon A.K., Williams O., Mongkolsapaya J., Jin B., Xu X.N., Walczak H., Screaton G.R. Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: sensitivity of human thymocytes. Proc Natl Acad Sci USA 2001, 98:5158-5163.
54. Cretney E., Uldrich A.P., Berzins S.P., Strasser A., Godfrey D.I., Smyth M.J. Normal thymocyte negative selection in TRAIL-deficient mice. J Exp Med 2003, 198:491-496.
55. Cretney E., Uldrich A.P., McNab F.W., Godfrey D.I., Smyth M.J. No requirement for TRAIL in intrathymic negative selection. Int Immunol 2008, 20:267-276.
56. Lamkanfi M., Festjens N., Declercq W., Vanden Berghe T., Vandenabeele P. Caspases in cell survival, proliferation and differentiation. Cell Death Differ 2007, 14:44-55.
57. Doerfler P., Forbush K.A., Perlmutter R.M. Caspase enzyme activity is not essential for apoptosis during thymocyte development. J Immunol 2000, 164:4071-4079.